"Plasmapheresis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use.
| Descriptor ID |
D010956
|
| MeSH Number(s) |
E02.120.770 E02.912.715
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Plasmapheresis".
Below are MeSH descriptors whose meaning is more specific than "Plasmapheresis".
This graph shows the total number of publications written about "Plasmapheresis" by people in this website by year, and whether "Plasmapheresis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2017 | 3 | 9 | 12 |
| 2018 | 3 | 5 | 8 |
| 2019 | 3 | 1 | 4 |
| 2020 | 3 | 10 | 13 |
| 2021 | 4 | 2 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Plasmapheresis" by people in Profiles.
-
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).
-
Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis. Front Immunol. 2021; 12:711915.
-
How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
-
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-ß. J Clin Immunol. 2021 10; 41(7):1425-1442.
-
Plasmapheresis Efficiency in Coronavirus Disease 2019: More Related to What You Add and Not What You Take Away? Crit Care Med. 2021 06 01; 49(6):e651-e652.
-
Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption. Am J Respir Crit Care Med. 2021 06 01; 203(11):1433-1435.
-
Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection. Blood Coagul Fibrinolysis. 2021 Jun 01; 32(4):294-297.
-
A case report of COVID-19 in refractory myasthenia: Outcome with remdesivir and dexamethasone. Medicine (Baltimore). 2021 May 07; 100(18):e25701.
-
Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology-enabled nomogram. Transfusion. 2021 06; 61(6):1789-1798.
-
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis. J Allergy Clin Immunol. 2021 07; 148(1):96-98.